Cardiff Oncology, Inc.
CRDF- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001213037
In the last 90 days, Cardiff Oncology, Inc. insiders filed 2 open-market purchases and 0 sales; 104 institutions reported holding it in 13F filings for Q2 2026, worth $24.2M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Cardiff Oncology, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- +4 vs. Q2 2021
- Shares held
- 21.1M
- −5.41M (−20.4%) vs. Q2 2021
- Total value
- $140.7M
- −$35.7M (−20.2%) vs. Q2 2021
- New holders
- 19
- 30 more added
- Sold out
- 15
- 26 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRDF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $24.2M |
| Q1 2026 | 117 | $39.7M |
| Q4 2025 | 110 | $76.6M |
| Q3 2025 | 112 | $51.9M |
| Q2 2025 | 115 | $90.3M |
| Q1 2025 | 116 | $101.6M |
| Q4 2024 | 117 | $121.9M |
| Q3 2024 | 83 | $34.1M |
| Q2 2024 | 90 | $29.1M |
| Q1 2024 | 77 | $45.8M |
| Q4 2023 | 55 | $7.84M |
| Q3 2023 | 56 | $7.58M |
| Q2 2023 | 53 | $8.81M |
| Q1 2023 | 55 | $11.6M |
| Q4 2022 | 60 | $10.8M |
| Q3 2022 | 58 | $12.2M |
| Q2 2022 | 67 | $19.6M |
| Q1 2022 | 91 | $41.0M |
| Q4 2021 | 87 | $132.1M |
| Q3 2021 | 94 | $140.7M |
| Q2 2021 | 90 | $176.4M |
| Q1 2021 | 73 | $223.0M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Cardiff Oncology, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jump Financial, LLC | 0 | $0 | 0.00% | −44,100−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −26,167−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −24,214−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −20,109−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −19,925−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −15,335−100.0% | Sold out |
| Vigilare Wealth Management | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −882−100.0% | Sold out |
| Glen Eagle Advisors, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |